Vectors Research Management’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$508K Hold
2,140
0.13% 106
2026
Q1
$452K Hold
2,140
0.13% 106
2025
Q4
$440K Hold
2,140
0.13% 97
2025
Q3
$336K Hold
2,140
0.11% 112
2025
Q2
$360K Hold
2,140
0.12% 96
2025
Q1
$295K Hold
2,140
0.1% 97
2024
Q4
$253K Hold
2,140
0.09% 106
2024
Q3
$235K Hold
2,140
0.07% 116
2024
Q2
$210K Hold
2,140
0.06% 125
2024
Q1
$239K Hold
2,140
0.07% 125
2023
Q4
$217K Buy
+2,140
New +$212K 0.06% 136
2023
Q3
Sell
-2,140
Closed -$202K 125
2023
Q2
$202K Buy
+2,140
New +$181K 0.06% 135
2022
Q3
Sell
-2,140
Closed -$112K 194
2022
Q2
$112K Hold
2,140
0.03% 167
2022
Q1
$121K Hold
2,140
0.03% 173
2021
Q4
$110K Hold
2,140
0.02% 199
2021
Q3
$106K Hold
2,140
0.03% 192
2021
Q2
$122K Hold
2,140
0.03% 180
2021
Q1
$130K Buy
+2,140
New +$118K 0.04% 167

Other funds holding CAH

Vectors Research Management's CAH Position: Q2 2026 in Review

Vectors Research Management held its Cardinal Health (CAH) position steady in Q2 2026 at 2,140 shares worth $508K. The position accounts for 0.13% of the portfolio, ranked #106.

Vectors Research Management first reported a position in CAH in Q1 2021 and has held it in 18 quarters since. 1,492 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Vectors Research Management held 2,140 shares of Cardinal Health worth $508K as of Q2 2026.
  • Vectors Research Management left its Cardinal Health share count unchanged in Q2 2026.
  • Cardinal Health made up 0.13% of Vectors Research Management's portfolio in Q2 2026, its #106 holding.
  • Vectors Research Management first reported a position in Cardinal Health in Q1 2021 and has held it in 18 quarters since.
  • 1,492 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Vectors Research Management's 13F filing for Q2 2026, filed 29 Jul 2026.